Compare
Compare Drug Products
Pharmacies sometimes switch which manufacturer's version of a drug they stock. Enter both product names or DINs — usually printed right on the label or bottle — to see how they compare.
First product
vsOMNIPAQUE 180
Second product
OMNIPAQUE 300 LIQ IV SAR 647MG/ML
This comparison shows regulatory facts from Health Canada. It does not determine whether these products are interchangeable — ask your pharmacist before switching.
↔ Swipe to see both products
| OMNIPAQUE 180 | OMNIPAQUE 300 LIQ IV SAR 647MG/ML | |
|---|---|---|
| Manufacturer | GE HEALTHCARE CANADA INC | SANOFI CANADA, INC. |
| Active ingredient | IOHEXOL | — |
| Strength | 388MG | — |
| Dosage form | SOLUTION | — |
| Route | SUBARACHNOIDAL | — |
| Health Canada status | Cancelled Post Market | — |
| Shortage status | Permanently Discontinued | No current shortage |
| Recall / safety alert | None on file | None on file |
Not enough data to compareNot enough data to compareNot enough data to compareNot enough data to compare